Try our Advanced Search for more refined results
Health - November, 2011
210 articles
- Ex-Olympus CEO Quits Board, Wants New Management
- National Century Exec's Sentence Cut In $2.4B Fraud Suit
- Boehringer Loses Bid To Decertify Sales Rep OT Action
- AAI Presses FTC To Block Express Scripts' Buy Of Rival
- Investors Sue Abbott Over $1.5B Depakote Settlement Tab
- Genentech Settles FCA Suit Over Cancer Drug For $20M
- Baxter Not Obliged To Ensure Meal Breaks Are Taken: Judge
- Creating An E-Discovery Process For Google Apps
- Unsealed FCA Suit Accuses Pfizer Of Off-Label Marketing
- Pfizer Told To Cough Up Docs In Drug Marketing Action
- Pharmasset Investor Challenges $11B Gilead Deal
- Bribery Charges Land NY Assemblyman In Hot Water Again
- Health Canada Bans Avastin For Breast Cancer Treatment
- EMSC, Shareholders Reach Settlement Over $3B Sale
- Allergan Sues Apotex Again Over Generic Pinkeye Drug
- Dearth Of A 'Sales'man
- The Changing Scope Of Expert Witness Disclosures
- Bass Berry Backs HCP In Polaris Hospital Growth Buy
- Lens Maker Sued Over Hazy Quality Control Standards
- Health Systems, Insurer Sent To Mediation In Antitrust Row
- FDA Chemist Settles Insider Trading Suit For $4M
- Producer Pleads Guilty To $2.6M Insider Trading Scheme
- Facebook Takes Responsibility For Merck Mix-Up
- AMO, Consumers Settle Contact Lens Marketing Action
- Pharmacies Turned Away By High Court In W.Va. Drug Suit
- ArthroCare To Pay $74M To End Stock Inflation Action
- Fordham Professor To Lead Fosamax Settlement Talks
- Bayer WeightSmart Class Gets Nod In False Ad Fight
- Supreme Court To Rule On GSK Reps' OT Status
- Giving Credit Where Credit Is Due
- Allergan Investors Sue Board Over Tax Tab For Exec Pay
- Histogen Scrubs SkinMedica Skin-Care Patent Suit
- 8th Circ. Won't Rehear Heart Defect Drug Competition Suit
- Merck KGaA Accuses Merck & Co. Of Facebook Ambush
- Sutter Health Hit With Data Theft Class Action
- State Insurance Heads Want Changes To Loss Ratio Rule
- Warner Targets Mylan's Plans For Generic Contraceptive
- Silver Oak Says UBS Played Dumb On MediCor Ponzi Plot
- 7th Circ. Cries Fowl Over Attys' Transfer Briefs
- What Sets SciClone's FCPA Derivative Suit Apart
- Smith & Nephew Says Hologic Cut Into Its Surgical Patent
- Graceway Cleared To Sell Assets To Medicis For $455M
- EU Agency Calls For Recall Of US-Made Cancer Drugs
- Quincy Medical Center's Ch. 11 Plan Gets Nod
- Merck To Pay Nearly $1B To Settle Vioxx Marketing Claims
- FDA Chides Mylan Over Puerto Rico Plant Violations
- More Reasons To Discount Adverse Event Reports
- Darvocet, Darvon Suits Must Be Nixed After Mensing: Lilly
- Mylan Asks Fed Circ. To End Doryx ANDA Injunction
- Ropes & Gray Helps Pfizer Buy Anti-Scar Drug Co.
- Aflac Strikes Deal In Action Over Child Premiums
- Allied Health Founder Gets 16 Years For $87M Fraud
- Siemens Targeted Over Medical Scan Patent
- Maxim Manager Gets 5 Months For Medicaid Fraud Role
- Synthes Execs Sentenced Over Bone Cement Trials
- MetroPlus Faces New OT Action From Marketing Reps
- Novartis, Mylan Settle Feud Over Generic Vivelle-Dot
- Teva, Bayer Settle Dispute Over Levitra Patents
- PE Firm Ratos Sells 2 Cos. To 3D Systems For $137M
- 7th Circ. Affirms Lovenox Kickback Case Conviction
- Pfizer To Settle FCPA Bribery Probe For $60M
- Actelion To Appeal $415M Verdict Over CoTherix Buy
- Takeda Targets Rival Over Generic Diabetes Drug
- Duane Morris Woos 2 Deals Experts For Calif. Offices
- Looking For Loopholes In PLIVA V. Mensing
- Gilead Expands Hep C Efforts In $11B Skadden-Led Buy
- Olympus Panel Finds No Connection To Organized Crime
- When A Hospital Becomes A No-Standing Zone
- Valeant Buys INova From PE Firms For $688M
- Ex-Synthes Execs To Be Sentenced For 'Rogue' Trials
- Supreme Court Picks 2 Attys For Health Care Fight
- FTC Sues To Block Illinois Hospital Merger
- Novartis Bone Drug Suit Falls Under NJ Damages Law: Court
- Bankrupt Graceway Faces Copyright Suit Over Drug Promos
- Judge Slims Malpractice Suit Against Strapp, Horvitz
- FrontPoint's Skowron Gets 5 Years For Insider Trading
- Fighting Reverse Payments In The Drug Industry
- FDA Bars Avastin's Use As Breast Cancer Treatment
- FTC's Rosch Slams ACOs As Detrimental To Costs, Care
- Kirkland Helps Bain Repurchase Physio-Control For $487M
- Kan. Hospital Warns 8K Patients Of Data Breach By Biller
- Watson Ducks Ky. Drug Price Inflation Suit
- 4 Trends Health Care Employers Should Watch
- Health Benefit Manager Expands Base In $250M Deal
- Storing Infant Blood Violates Privacy: Minn. Top Court
- FDA Withholding Evidence In Birth Defects Suit: Attys
- Ex-Abbott Drug Rep Exempt From OT, Judge Says
- 9th Circ. To Rehear Veterans' Mental Health Care Action
- CooperVision Widens Contact Lens Recall
- Cigna Offers 15M Shares To Fund $4B HealthSpring Buy
- Sandoz, States Settle Drug Inflation Claims For $150M
- Conn. Teeth-Whitening Rules Violate Constitution: Suit
- Mayer Brown Asks 7th Circ. To Fine Trustee Over $17M Suit
- The Truth Is Out There, But Not Always On The Label
- FTC Nominees Weigh In On Pay-For-Delay Deals, Privacy
- Sens. Blast FDA's 'Slow' Device Approval Process
- APP Takes Angiomax Patent Extension Fight To Fed. Circ.
- Wyeth Resolves False Ad Fight Against Sun In 6th Circ.
- China Fines Cos. $1M Over Drug Ingredient Monopoly
- Judge Refuses To Trim Norton Workers' ERISA Action
- Olympus Investor Sues Over Merger Fee Scandal
- Blue Cross Sued Over 'Bait And Switch' Deductible Hikes
- Bard Ends Vessel Graft Patent Feud With Endologix
- Patent Group Rips America Invents In Tylenol Marking Suit
- Samsung Boosts Medical Market Presence With Nexus Buy
- Merck Strikes Deal With Fla., NY, SC Over Vioxx Claims
- Anadys Shareholders Challenge $230M Sale To Roche
- Fresenius Wants Supplier To Cover Dialysis Device Recall
- Allergan Takes Aim At Lupin Over Lumigan ANDA
- Novartis Backs Medical Test Patent In High Court
- Clawing Back Overpayments From Health Care Providers
- Health Subcontractor Seeks Coverage For $78M Settlement
- Contractors Struggle To Root Out Medicare Fraud: Report
- Failure-To-Warn Claims Need Fail-Proof Evidence In NJ
- Class OK'd In Bayer Men's Vitamin False Ad Suit
- Supreme Court Takes Up Health Care Reform
- NY Pol Found Not Guilty In Hospital Bribe Case
- ITC Refuses To OK Amgen, Roche Anemia Drug Deal
- HIG Adds 2 Sell-Offs To Recent Spate Of Deals
- FDA Unveils New Rules To Speed Up Medical Device Studies
- Aurora Health Settles Security Workers' Meal Break Suit
- MSNBC Sued For Profits From Film About MJ's Doctor
- FDA Warns Int'l Isotopes Over Unapproved Thyroid Drug
- 6th Circ. Nixes Health Discount Deceptive Ads Action
- Fed. Circ. Nixes Teva Bid To Halt Generic Seasonique
- J&J Wants Rivals' Marketing Data In Omnicare FCA Row
- McDermott Sues DOJ For Hospital Docs In Antitrust Probe
- Tightening The Noose Around TPP Claims
- Galderma Targets Amneal's Generic Rosacea Treatment
- HIPAA Enforcement Lacks Teeth Despite Changes: Panel
- Medco, Investors Settle Over $29B Express Scripts Merger
- DOJ Subpoenas Merck Over Avelox, Integrilin Marketing
- Healix Seeks To Duck $7M Video Game Arbitration Payout
- Abbott Can't Escape Suit Over Humira's Cancer Risks
- Frazier, Vivo Add To Rempex's $67.5M In Fundraising
- Merck Settles ERISA Suit Over Vioxx Claims For $50M
- Affymax To Pay J&J Unit $13M In Anemia Drug IP Dispute
- Back To The Future With Medicare Bundled Payments
- Ore. Says McKesson Artificially Inflated Drug Prices
- Toxic Torts: Designation For Causation
- PE Firm HIG Sheds 2 Cos. In Flurry Of Moves
- Cuomo Tells 11 Insurers To Refund $114.5M To Customers
- HCP To Pay Ventas Extra $125M In REIT Purchase Row
- Ohio Voters Allow Health Care Reform Opt-Outs
- GSK Prodded Toward Mediation In Avandia MDL
- Calif. Pharmacies Sue Pfizer, Ranbaxy Over Lipitor Deal
- Warner Chilcott Targets Cadila Over Generic Asacol
- Sens. Probe Cigna, Quest, Others Over Lab Kickbacks
- St. Jude Vascular Device Patent Protected By Law: Judge
- 5th Circ. Revives State Claims In Health Provider Suit
- US Regulators On Short Leash With Olympus Probe
- DOJ Settles Antitrust Suit Over $26M Blue Cross Deal
- 9th Circ. Keeps Investor Class Intact In Anemia Drug Fight
- Amylin, Lilly Wrap Up Diabetes Drug Alliance, Lawsuit
- Goodwin Helps TA Snag Senior Whole Health For $135M
- Atty Denies Lying To Block $188M Fraud Judgments
- Savient Investor Asks 2nd Circ. To Reopen Fraud Case
- AstraZeneca Indicted In Serbia Over Doctor Payments
- DC Circ. Backs Health Care Law's Individual Mandate
- Antitrust Issues In Bilateral Monopolies
- Federal Preemption For Generic OTC Drugs?
- Olympus Admits To Hiding Losses With Merger Fees
- Judge Finds Valeant's Antidepressant Patents Valid
- Pfizer, Aurobindo Reach Accord In Lipitor Patent Case
- CVS, KV Resolve $100M Suit Over Drug Supply Contract
- Knee Device Maker Sues Plaintiffs Firm Over Ads
- SAIC To Monitor Data Breach Victims' Credit: DOD
- Quest, Debt Collectors Duck RICO Claims In Billing Suit
- TA Associates Sheds Kidney Treatment Centers
- Amgen Launches $5B Stock Buyback, Senior Notes Offering
- DLA Piper Lures Deals Partner From Sheppard Mullin
- Allergan Faces Medicaid Fraud Probe By Mass. AG
- AstraZeneca Asks Fed. Circ. To Bar Generic Crestor
- Simpson Aids JLL In $398M American Dental Purchase
- Lilly Wins First Zyprexa Liability Trial
- Takeda Sued Again Over Diabetes Drug's Cancer Risks
- Cigna Beats RICO Claims In Hospital's $30M Payment Suit
- FDA Overrules Staff To Broaden Approval Of J&J's Xarelto
- Great Point Grabs Stake In Remote Radiology Startup
- Hospital Workers Ask 1st Circ. To Reverse OT Ruling
- What The New ACO Guidelines Tell Us About Antitrust
- Novartis Fights Actavis' Generic Dementia Patch
- EU Puts Spotlight On $21B J&J-Synthes Merger
- Acella Clears Up Medicis Acne Treatment Patent Suit
- Siemens Buys MobileMD To Boost Health Care IT Offerings
- Judge Nixes Last 2 Wrongful Death Suits In Digitek MDL
- 10th Circ. Upholds FDA Win In Morphine Exemption Suit
- Reed Smith Health Privacy Atty Jumps To King & Spalding
- Validus Plans Board Battle To Close Transatlantic Deal
- The Vanishing Civil Trial Lawyer
- GSK To Pay $3B To Settle US Avandia, Medicaid Probes
- Pharm Co. Breckenridge Sues Rivals Over Generic Laxative
- Cephalon Targets Breckenridge Over Nuvigil Patent
- Pharma Tech Co. Targets Rival Over Tracking Device IP
- Sandoz Settles Iowa, NY Drug Price Inflation Claims
- Adolor Investor Challenges Cubist's $415M Takeover Bid
- HSG Gene Sequence Patent Valid: UK High Court
- AXA Private Equity Carves Out Rhodia's Aspirin Unit
- Quinn Emanuel Adds Departing Novartis GC In Europe
- Express Scripts, Medco Deal Slammed By Small Biz Group
- ACO Final Rule: The Opportunity Cost
- UMass Hospitals Are 1 Employer, Workers Tell 1st Circ.
- DOJ Wants In On FCA, Kickback Suit Against Hospital
- 9th Circ. Nixes Union Action Over Hospital Layoffs
- Stiefel Will Get Split Trial For ERISA, Stock Fraud Claims
- Omega Healthcare Snaps Up 3 Mid-Atlantic Nursing Homes
- Hogan Lovells Guides Glucose Tester In $54M Fundraising
- FTC Gives Go-Ahead To $725M Lab Testing Merger
- Novartis Shakes Suit Over Bone Drug Warnings
- Olympus Committee To Probe Merger Fee Scandal